The evolution of genetic sequencing: from “chips” to RNA sequencing and single-cell analysis

Andrew Donson, Senior Research Associate The Morgan Adams Foundation Pediatric Brain Tumor Research Program at the University of Colorado Anschutz Medical Campus & Children’s Hospital Colorado Andy Donson has been an integral member of the research team since the lab first opened its doors more than 25 years ago. “I was a biochemistry major in…


Research identifies ‘genetic switch’ that may protect brain cancer stem cells

Chemotherapy and radiation kill rapidly dividing cells, a hallmark of cancer (and hair). However, cancer stem cells do not divide rapidly and so tend to resist these treatments. And while these stem cells make up only a small percentage of a tumor’s bulk, if only a small population survives treatment, they can often regrow a…


MAF Researchers secure federal grants and publication

There was quite a lot for researchers in the Morgan Adams Foundation Brain Tumor Research Program to celebrate in February! Dr. Nick Foreman’s group was awarded TWO large federal grants to continue their industry-leading research of ependymoma. First, an RO1 from the National Institutes of Health (NIH) / National Cancer Institute (NCI) will support an…


International collaboration enables MAF researchers to apply for grant worth $9.6 million

Nick Foreman, MD, the Seebaum-Tschetter Chair of Pediatric Neuro-Oncology at Children’s Hospital Colorado, has been leading the way in moving groundbreaking kids’ cancer research from the lab to the clinic in Colorado for more than two decades.  Dr. Foreman’s prescient decision to collect and store tumor samples means the Morgan Adams Foundation Pediatric Brain Tumor…


Newsletter Fall 2017 Page 2